Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Biochemical Society Transactions|November 10, 2015
Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interactionGeoff WellsBiochemical Society Transactions|June 9, 2023
Small molecule and peptide inhibitors of βTrCP and the βTrCP-NRF2 protein-protein interactionUzma Jaffry, Geoff WellsNature Chemical Biology|January 20, 2017
The pharmacological regulation of cellular mitophagyNikolaos D Georgakopoulos, Geoff Wells, Michelangelo CampanellaOrganic & Biomolecular Chemistry|April 26, 2013
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activityRowena Hancock, Marjolein Schaap, Helene Pfister, et al.Protein Science : a Publication of the Protein Society|October 17, 2013
Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interactionMarjolein Schaap, Rowena Hancock, Andrew Wilderspin, et al.Science (New York, N.Y.)|October 5, 2023
Confronting deep uncertainty in the forest carbon industryGeoff Wells, Unai Pascual, Chris Stephenson, et al.Acta Crystallographica. Section D, Structural Biology|November 2, 2021
The future of biomolecular simulation in the pharmaceutical industry: what we can learn from aerodynamics modelling and weather prediction. Part 1. understanding the physical and computational complexity of in silico drug designTom Edwards, Nicolas Foloppe, Sarah Anne Harris, et al.Molecules (Basel, Switzerland)|March 14, 2020
Synthesis and Biological Evaluation of a Novel C8-Pyrrolobenzodiazepine (PBD) Adenosine Conjugate. A Study on the Role of the PBD Ring in the Biological Activity of PBD-ConjugatesLindsay Ferguson, Sanjib Bhakta, Keith R Fox, et al.Chembiochem : a European Journal of Chemical Biology|June 22, 2018
Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino AcidsNikolaos D Georgakopoulos, Sandeep K Talapatra, Jemma Gatliff, et al.Free Radical Biology & Medicine|October 1, 2022
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistanceRohini Srivastava, Raquel Fernández-Ginés, José Antonio Encinar, et al.Pageof 3